Board Stats

Gilead Sciences, Inc.

Y! GILD - BLOG Optionistics CBOE Options Calculator Options Profit Calculator MAX - Pain Gilead Analysts IV Tutorials

GILD / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
12090	Gilead stock jumps 5% after Q4 beat, dividend increase	GN	jerrykrause		0	2/3/2023 3:42:17 PM

12089	Gilead's breast cancer drug gets U.S. FDA approval for third indication	GN	jerrykrause		0	2/3/2023 3:39:48 PM

12088	Gilead's Yescarta set to become England's first routinely available personalized immu	GN	jerrykrause		1	1/27/2023 1:15:25 PM

12087	Gilead adds lupus, arthritis therapies with EVOQ alliance	GN	jerrykrause		0	1/5/2023 12:37:17 PM

12086	Gilead Sciences to Acquire Remaining Rights to GS-1811 from Jounce Therapeutics	GN	jerrykrause		0	12/28/2022 7:34:47 PM

12085	Gilead To Acquire All Remaining Rights To Potential First-In-Class Immunotherapy GS-	GN	jerrykrause		0	12/28/2022 7:11:49 PM

12084	Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Int	GN	jerrykrause		0	11/29/2022 4:44:02 PM

12083	Gilead Stock Jumps as 2 Analysts Turn Upbeat	GN	jerrykrause		1	10/28/2022 7:04:46 PM

12082	Gilead Has Growth Potential in HIV and Oncology Franchises, Analyst Says	GN	jerrykrause		0	10/4/2022 5:01:16 PM

12081	Gilead's Veklury receives WHO recommendation to treat severe Covid-19	GN	jerrykrause		1	9/17/2022 10:48:50 AM

Go to Msg #

BOARDS Sign In for Filters